Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 2, 2000, Pages 127-132

  Gallo, Daniela ^a   Ferlini, Cristiano ^a   Distefano, Mariagrazia ^a   Cantelmo, Fabio ^a   Gaggini, Cristiana ^a   Fattorossi, Andrea ^a   Riva, Antonella ^c   Bombardelli, Ezio ^c   Proietti, Enrico ^b   Mancuso, Salvatore ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NONE

Author keywords

Apoptosis; Cervical cancer; Taxanes; Tubulin

Indexed keywords

DOCETAXEL; ORTATAXEL; PACLITAXEL; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT; UTERINE CERVIX CANCER;

EID: 0033972820     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050020     Document Type: Article

References (24)

1. 1. Andreu JM, Diaz JF, Gil R, Pereda JM De, Garcia LM De, Peyrot V, Briand C, Towns AE, Bordas J (1994) Solution structure of Taxotere-induced microtubules to 3-nm resolution. The change in protofilament number is linked to the binding of the taxol side chain. J Biol Chem 269: 31785
2. 2. Blagosklonny MV, Giannakakou P, El-Deiry WS, Kingston DG, Higgs PI, Neckers L, Fojo T (1997) Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 57: 130
3. 3. Chen MD, Paley PJ, Potish RA, Twiggs LB (1997) Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer. Gynecol Oncol 67: 131
4. 4. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27: 1
5. 5. Distefano M, Scambia G, Ferlini C, Gaggini C, De Vincenzo R, Riva A, Bombardelli E, Ojima I, Fattorossi A, Panici PB, Mancuso S (1997) Anti-proliferative activity of a new class of taxanes (14β-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells. Int J Cancer 72: 844
6. 6. Erlich E, McCall AR, Potkul RK, Walter S, Vaughan A (1996) Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Gynecol Oncol 60: 251
7. 7. Ferlini C, Biselli R, Scambia G, Fattorossi A (1996) Probing chromatin structure in the early phases of apoptosis. Cell Prolif 29: 427
8. 8. Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A (1996) Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 24: 106
9. 9. Franco EL (1991) Viral etiology of cervical cancer: a critique of the evidence. Rev Infect Dis 13: 1195
10. 10. Frattini MG, Hurst SD, Lim HB, Swaminathan S, Laimins LA (1997) Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumour suppressor protein. Embo J 16: 318
11. 11. Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507
12. 12. Horwitz SB, Lothstein L, Manfradi JJ, Mellado W, Parness J, Roy SN, Schiff PB, Sorbara L, Zeheb R (1986) Taxol: mechanisms of action and resistance. Ann N Y Acad Sci 466: 733
13. 13. Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, LoCoco S, Umbreit J, Delmore JE, Arbuck S, Loyer E, Gacrama P, Fueger R, Kavanagh JJ (1997) An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 8: 657
14. 3H](Azidophenyl)ureido taxoid photolabels peptide amino acids 281-304 of α-tubulin. Biochemistry 36: 3820
15. 15. Ojima I, Slater JC, Michaud E, Kuduk SD, Bounaud PY, Vrignaud P, Bissery MC, Veith JM, Pera P, Bernacki RJ (1996) Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J Med Chem 39: 3889
16. 16. Oridate N, Lotan D, Mitchell MF, Hong WK, Lotan R (1995) Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J Cell Biochem 23: 80
17. 17. Papadimitriou CA, Sarris K, Moulopoulos LA, Fountzilas G, Anagnostopoulos A, Voulgaris Z, Gika D, Giannakoulis N, Diakomanolis E, Dimopoulos MA (1999) Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 17: 761
18. 18. Polizzi D, Pratesi G, Tortoreto M, Supino R, Riva A, Bombardelli E, Zunino F (1999) A novel taxane with improved tolerability and therapeutic activity in a panel of human tumour xenografts. Cancer Res 59: 1036
19. 19. Slichenmyer WJ, Von Hoff DD (1991) Taxol: a new and effective anti-cancer drug. Anticancer Drugs 2: 519
20. 20. Sparreboom A, Tellingen O Van, Nooijen WJ, Beijnen JH (1998) Preclinical pharmacokinetics of paclitaxel and docetaxel. Anticancer Drugs 9: 1
21. 21. Thomas JT, Laimins LA (1998) Human papillomavirus onco-proteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J Virol 72: 1131
22. 22. Vasey PA, Jones NA, Jenkins S, Dive C, Brown R (1996) Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. Mol Pharmacol 50: 1536
23. 23. Verweij J, Clavel M, Chevalier B (1994) Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind. Ann Oncol 5: 495
24. 24. Vogt HG, Martin T, Kolotas C, Schneider L, Strassmann G, Zamboglou N (1997) Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies. Semin Oncol 24: 101